Insider and congress filings
Zimmer Biomet Holdings, Inc. (ZBH)
Free on iOS and Android.
About Zimmer Biomet Holdings, Inc.
from the company's filings and listing, as of Oct 26, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Ivan Tornos
- Employees
- 17,000
- Listed since
- Jul 25, 2001
- Market value
- $18.8B
- Price to earnings (12 mo)
- 23.9
- Net income per share, as reported (12 mo)
- $4.20
- Dividend yield
- 0.97%
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $2.07 | $2.01 | $2.2B | $2.1B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 28, 2026 | $2.09 | $1.86 | $2.1B | $2.1B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 10, 2026 | $2.42 | $2.38 | $2.2B | $2.2B | EPS beatRevenue in line |
| Q3 FY2025reported Nov 5, 2025 | $1.90 | $1.87 | $2.0B | $2.0B | EPS beatRevenue in line |
| Q2 FY2025reported Aug 7, 2025 | $2.07 | $1.98 | $2.1B | $2.1B | EPS beatRevenue in line |
| Q1 FY2025reported May 5, 2025 | $1.81 | $1.77 | $1.9B | $1.9B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 1, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Ivan TornosChairman, President and CEO | $1.3M | $12.0M | $2.8M | $16.1M |
| Jehanzeb NoorSVP, Chief Strategy, Business Development, Innovation and Transformation Officer | $683K | $5.1M | $2.1M | $7.9M |
| Suketu UpadhyayCFO and EVP - Finance, Operations and Supply Chain | $907K | $4.0M | $1.3M | $6.2M |
| Kevin ThornalGroup President, Global Businesses and the Americas | $405K | $5.3M | $505K | $6.2M |
| Wilfred van ZuilenGroup President, EMEA | $743K | $2.0M | $1.4M | $4.1M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| Dodge & Cox | $2.1B | 24,124,735 | +2.5% | 12.55% |
| BlackRock, Inc. | $1.3B | 15,614,847 | +1.8% | 8.12% |
| Harris Associates L.P. | $1.1B | 12,738,025 | -1.7% | 6.63% |
| Vanguard Capital Management LLC | $1.1B | 12,634,937 | -1.2% | 6.57% |
| Capital International Investors | $1.0B | 12,183,614 | +33.6% | 6.34% |
| State Street Corp | $766.3M | 8,877,171 | +0.6% | 4.62% |
| Vanguard Portfolio Management LLC | $726.7M | 8,441,747 | -2.4% | 4.39% |
| Geode Capital Management, LLC | $458.7M | 5,349,223 | -0.6% | 2.78% |
| T. Rowe Price Associates, Inc. | $413.0M | 4,797,157 | -40.0% | 2.50% |
| Invesco Ltd. | $342.6M | 3,979,860 | +10.4% | 2.07% |
| Primecap Management Co | $328.6M | 3,816,680 | -2.3% | 1.99% |
| VanEck Associates Corp | $301.5M | 3,501,654 | -7.0% | 1.82% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
4 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Kevin R. ThornalGrp Pres-Global Business | Sold | 5,691 | $92.95 | $529K | Sep 11, 2026filed Sep 15, 2026 | 2d |
| Chad F. Phipps | Sold | 3,000 | $98.35 | $295K | Sep 4, 2026filed Sep 9, 2026 | 2d |
| Sang YiGroup President, Asia Pacific | Sold · 2 lines | 5,000 | $82.64 | $413K | May 29, 2026filed Jun 2, 2026 | 2d |
| Lori WinklerSVP and CHRO | Sold | 2,650 | $94.66 | $251K | Mar 12, 2026filed Mar 16, 2026 | 2d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Gary Craig CampbellPresident, Americas | Tax withholding | 1,412 | Oct 1, 2026 |
| Gary Craig CampbellPresident, Americas | Option exercise | 3,586 | Oct 1, 2026 |
| Gary Craig CampbellPresident, Americas | Other Form 4 entry (see filing) | 13,345 | Oct 1, 2026 |
| Brian Matthew HatcherPresident, Recon, SET, Cmft | Other Form 4 entry (see filing) | 22,800 | Oct 1, 2026 |
| Michael J. FarrellDirector | Stock award | 417 | Sep 30, 2026 |
| Robert HagemannDirector | Stock award | 306 | Sep 30, 2026 |
| Louis ShapiroDirector | Stock award | 153 | Sep 30, 2026 |
| Arthur J. HigginsDirector | Stock award | 306 | Sep 30, 2026 |
| Devdatt KurdikarDirector | Stock award | 174 | Sep 30, 2026 |
| Maria Teresa HiladoDirector | Stock award | 376 | Sep 30, 2026 |
| Sreelakshmi KolliDirector | Stock award | 174 | Sep 30, 2026 |
| Chintan DesaiPresident, APAC | Stock award | 10,168 | Aug 3, 2026 |
| Kevin R. ThornalGrp Pres-Global Business | Tax withholding | 4,266 | Aug 1, 2026 |
| Kevin R. ThornalGrp Pres-Global Business | Option exercise | 9,957 | Aug 1, 2026 |
| Louis ShapiroDirector | Stock award | 159 | Jun 30, 2026 |
| Michael J. FarrellDirector | Stock award | 433 | Jun 30, 2026 |
| Sreelakshmi KolliDirector | Stock award | 180 | Jun 30, 2026 |
| Arthur J. HigginsDirector | Stock award | 317 | Jun 30, 2026 |
| Robert HagemannDirector | Stock award | 317 | Jun 30, 2026 |
| Devdatt KurdikarDirector | Stock award | 180 | Jun 30, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in ZBH
20 disclosures of 109 on record · median 25d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +9.8%After the saleS&P 500 +1.2% · +8.7 pts vs S&P 500 | Jul 6, 2026 | Aug 7, 2026 | 32d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +9.8%After the saleS&P 500 +1.2% · +8.7 pts vs S&P 500 | Jul 6, 2026 | Aug 7, 2026 | 32d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +4.8%After the saleS&P 500 +1.5% · +3.3 pts vs S&P 500 | Jul 13, 2026 | Aug 7, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +9.9%After the saleS&P 500 +2.9% · +7.0 pts vs S&P 500 | Jul 23, 2026 | Aug 7, 2026 | 15d |
| Alan ArmstrongSelf | Stock | Purchase | $1,001 - $15,000 | +11.3%S&P 500 +19.8% · -8.5 pts vs S&P 500 | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +18.9%After the saleS&P 500 +5.4% · +13.5 pts vs S&P 500 | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +19.3%S&P 500 +1.6% · +17.7 pts vs S&P 500 | May 14, 2026 | Jun 9, 2026 | 26d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +17.8%After the saleS&P 500 +2.8% · +14.9 pts vs S&P 500 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +19.4%S&P 500 +1.3% · +18.1 pts vs S&P 500 | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +12.3%After the saleS&P 500 +15.6% · -3.3 pts vs S&P 500 | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +6.9%After the saleS&P 500 +14.1% · -7.1 pts vs S&P 500 | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +1.5%After the saleS&P 500 +11.2% · -9.8 pts vs S&P 500 | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +1.5%S&P 500 +11.2% · -9.8 pts vs S&P 500 | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +11.6%S&P 500 +9.5% · +2.1 pts vs S&P 500 | Jan 13, 2026 | Feb 6, 2026 | 24d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.8%S&P 500 +10.2% · +3.6 pts vs S&P 500 | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +14.6%S&P 500 +9.5% · +5.1 pts vs S&P 500 | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +10.4%S&P 500 +10.0% · +0.4 pts vs S&P 500 | Jan 14, 2026 | Feb 6, 2026 | 23d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -1.3%S&P 500 +11.2% · -12.5 pts vs S&P 500 | Nov 3, 2025 | Dec 8, 2025 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +11.4%S&P 500 +13.4% · -2.0 pts vs S&P 500 | Nov 6, 2025 | Dec 8, 2025 | 32d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +11.1%After the saleS&P 500 +11.5% · -0.4 pts vs S&P 500 | Nov 10, 2025 | Dec 8, 2025 | 28d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in ZBH, filterable by party, chamber, type and account.
Questions
Are insiders buying or selling ZBH?
Across the 4 most recent open-market filings shown here, 0 were purchases and 4 were sales.
Which members of Congress have traded ZBH?
Ro Khanna and Alan Armstrong disclosed ZBH transactions in the filings shown here.
Is ZBH in the S&P 500 or the Nasdaq 100?
Zimmer Biomet Holdings, Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.
How quickly are ZBH trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.